
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Lactobacillus casei Shirota is a patented probiotic strain that produces antimicrobial compounds including bacteriocins and lactic acid to inhibit pathogenic bacteria. It specifically colonizes the small intestine and modulates immune responses through interaction with gut-associated lymphoid tissue.

Reported Benefits (Provisional)
Origin & History

Lactobacillus casei Shirota is a probiotic strain developed by Dr. Minoru Shirota in the 1930s. It is a key ingredient in Yakult, a popular probiotic drink.
Research Narrative (Provisional)
Clinical studies have shown that Lactobacillus casei Shirota can help maintain gut health and support the immune system, with several trials backing its efficacy.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
{"macronutrients": {"carbohydrates": "3.1g per 100ml", "protein": "1.0g per 100ml", "fat": "0.1g per 100ml"}, "micronutrients": {"calcium": "15mg per 100ml", "sodium": "15mg per 100ml", "potassium": "30mg per 100ml"}, "bioactive_compounds": {"Lactobacillus casei Shirota": "1.0 x 10^10 CFU per 100ml"}, "bioavailability_notes": "The probiotics in Yakult are designed to survive passage through the stomach, ensuring delivery to the intestines. The presence of live Lactobacillus casei Shirota enhances gut health and nutrient absorption."}
Reported Mechanism (Provisional)
Lactobacillus casei Shirota produces lactic acid and bacteriocins that create an acidic environment inhibiting pathogenic bacteria growth. The strain adheres to intestinal epithelial cells and stimulates secretory IgA production while modulating cytokine release from dendritic cells. It enhances tight junction proteins like claudin-1 and occludin to strengthen intestinal barrier function.
Clinical Narrative (Provisional)
Multiple randomized controlled trials with 50-400 participants demonstrate L. casei Shirota's efficacy in improving digestive health and immune markers. Studies show 40% increases in beneficial gut bacteria diversity and 30% improvements in immune function markers including increased NK cell activity. The strain has been extensively studied in Japan with over 100 published clinical trials. Evidence is strongest for digestive health benefits, with moderate evidence for immune support.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







